Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Drops By 46.5%

Applied DNA Sciences, Inc. (NASDAQ:APDN) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 3,000,000 shares, a decrease of 46.5% from the February 13th total of 5,610,000 shares. Approximately 5.4% of the company’s stock are short sold. Based on an average daily volume of 4,570,000 shares, the days-to-cover ratio is currently 0.7 days.

Applied DNA Sciences Trading Down 14.9 %

NASDAQ APDN opened at $2.26 on Friday. The firm has a market capitalization of $124.73 million, a P/E ratio of -0.40 and a beta of 0.43. The business has a fifty day simple moving average of $0.21 and a 200 day simple moving average of $0.42. Applied DNA Sciences has a 12 month low of $1.95 and a 12 month high of $522.00.

Applied DNA Sciences (NASDAQ:APDN) last released its earnings results on Thursday, February 13th. The technology company reported ($0.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.24). Applied DNA Sciences had a negative return on equity of 101.57% and a negative net margin of 228.12%. As a group, sell-side analysts predict that Applied DNA Sciences will post -0.87 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Millennium Management LLC purchased a new position in Applied DNA Sciences during the 4th quarter valued at about $28,000. Connective Capital Management LLC bought a new stake in Applied DNA Sciences in the 4th quarter worth approximately $36,000. Jane Street Group LLC bought a new stake in Applied DNA Sciences in the 3rd quarter worth approximately $48,000. Finally, Geode Capital Management LLC lifted its position in Applied DNA Sciences by 291.1% in the fourth quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company’s stock valued at $85,000 after purchasing an additional 310,749 shares during the last quarter. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.